| Name of epitope |
MHC binding |
Peptide sequence |
Immunogenicity |
| PASD1(1)38–47 |
HLA-A*0201 |
QLLDGFMIT |
IFNg secretion following MLR with patient T cells [64] . Demonstrated by IFNg ELISpot and CTL assays ex vivo [48] |
| PASD1(2)167-175 |
HLA-A*0201 |
YLVGNVCIL |
IFNg secretion following MLR with patient T cells [64] . Demonstrated by IFNg ELISpot and CTL assays ex vivo [48] |
| PASD1(6)31–50 |
HLA-DRB1 |
DYFNQVTLQLLDGFMITLST |
IFNg secretion following MLR with patient T cells [65] |
| PASD1(7)42–61 |
HLA-DRB1 |
DGFMITLSTDGVIICVAENI |
IFNg secretion following MLR with patient T cells [65] |
| Pw8/Pa14 |
HLA-A*0201 |
RLWQELSDS/RLWQELSDI |
IFNg secretion following MLR with patient T cells. Demonstrated by IFNg ELISpot and CTL assays ex vivo [63] |
